David Wong

Title: David Wong: Innovator in Solid Oral Pharmaceutical Composition

Introduction: David Wong, an accomplished inventor based in Taoyuan, Taiwan, has made significant contributions to the field of pharmaceuticals. With a focus on innovative medication formulations, he holds a patent that addresses key components in solid oral pharmaceutical compositions.

Latest Patents: David Wong is the inventor of a patented solid oral pharmaceutical composition. This formulation includes a first active ingredient, which is pitavastatin or a pharmaceutically acceptable salt thereof, and a second active ingredient, which is ezetimibe or a pharmaceutically acceptable salt thereof. The composition also contains at least one excipient, such as a diluent, stabilizing agent, disintegrant, binding agent, sweetener, lubricant, glidant, flavor, or coloring agent, among others. This innovative approach aims to enhance the effectiveness and accessibility of the medication.

Career Highlights: David Wong is currently employed at Orient Pharma Co., Ltd., where he continues to contribute to research and development in pharmaceuticals. His work showcases his dedication to advancing medical technology and improving patient outcomes through innovative drug formulations.

Collaborations: Throughout his career, David has collaborated with notable coworkers, including Chien-Yu Chen and Mongkol Sriwongjanya. Together, they foster a cooperative environment that promotes innovative thinking and development in the pharmaceutical industry.

Conclusion: David Wong is a prominent figure in the realm of pharmaceutical innovations. Through his patent for a solid oral pharmaceutical composition, he has demonstrated his commitment to improving drug formulations and ultimately enhancing healthcare. As a valuable member of Orient Pharma Co., Ltd., he continues to pave the way for future advancements in the field.